Longevity’s Reprogramming Moment: AI Drugs, Cellular Epigenetics, and Gut Microbiome Science Converge
Three landmark breakthroughs in longevity reprogramming research 2026 are reshaping what science knows about human aging. An AI-designed drug proves itself in clinical trials, the first human epigenetic reprogramming trial…
